Search research articles
Contact Us
Filters
Showing results (501-510 of 993) with videos related to
Page
of 100
Sort By:
American Journal of Clinical Oncology
|
May 30, 2020
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder
Stefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
Clinical Genitourinary Cancer
|
October 8, 2021
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
Benedikt Horlemann, Christoph Würnschimmel, Benedikt Hoeh, et al.
Prostate Cancer and Prostatic Diseases
|
September 14, 2021
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials
Bertrand F Tombal, Stephen J Freedland, Andrew J Armstrong, et al.
European Urology Oncology
|
August 15, 2019
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups
Felix Preisser, Marco Bandini, Sebastiano Nazzani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 2, 2010
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients
Naeem Bhojani, Umberto Capitanio, Nazareno Suardi, et al.
European Urology Focus
|
May 27, 2018
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database
Felix Preisser, Marco Bandini, Elio Mazzone, et al.
The Lancet. Oncology
|
June 9, 2018
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
Noel Clarke, Pawel Wiechno, Boris Alekseev, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2018
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study
Raisa S Pompe, Ariane Smith, Marco Bandini, et al.
Urologia Internationalis
|
August 4, 2016
Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database
Jonas Schiffmann, Alessandro Larcher, Maxine Sun, et al.
Page
of 100
Search research articles
Search
Showing results (501-510 of 993) with videos related to
Sort By:
Page
of 100
American Journal of Clinical Oncology
|
May 30, 2020
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder
Stefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
Clinical Genitourinary Cancer
|
October 8, 2021
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
Benedikt Horlemann, Christoph Würnschimmel, Benedikt Hoeh, et al.
Prostate Cancer and Prostatic Diseases
|
September 14, 2021
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials
Bertrand F Tombal, Stephen J Freedland, Andrew J Armstrong, et al.
European Urology Oncology
|
August 15, 2019
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups
Felix Preisser, Marco Bandini, Sebastiano Nazzani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 2, 2010
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients
Naeem Bhojani, Umberto Capitanio, Nazareno Suardi, et al.
European Urology Focus
|
May 27, 2018
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database
Felix Preisser, Marco Bandini, Elio Mazzone, et al.
The Lancet. Oncology
|
June 9, 2018
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
Noel Clarke, Pawel Wiechno, Boris Alekseev, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2018
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study
Raisa S Pompe, Ariane Smith, Marco Bandini, et al.
Urologia Internationalis
|
August 4, 2016
Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database
Jonas Schiffmann, Alessandro Larcher, Maxine Sun, et al.
Page
of 100